| Primary |
| Hypercholesterolaemia |
27.0% |
| Dyslipidaemia |
8.1% |
| Hypertension |
8.1% |
| Cardiac Failure |
5.4% |
| Diabetes Mellitus |
5.4% |
| Dyskinesia |
5.4% |
| Phlebitis |
5.4% |
| Anaemia |
2.7% |
| Arrhythmia |
2.7% |
| Arthralgia |
2.7% |
| Benign Prostatic Hyperplasia |
2.7% |
| Depression |
2.7% |
| Essential Thrombocythaemia |
2.7% |
| Hypopituitarism |
2.7% |
| Hypothyroidism |
2.7% |
| Infertility |
2.7% |
| Obesity |
2.7% |
| Oesophagitis |
2.7% |
| Osteoporosis |
2.7% |
| Thrombosis |
2.7% |
|
| Renal Failure |
12.0% |
| Inflammation |
8.0% |
| Intraventricular Haemorrhage |
8.0% |
| Rhabdomyolysis |
8.0% |
| Thrombocytopenia |
8.0% |
| Bone Marrow Failure |
4.0% |
| Epistaxis |
4.0% |
| Interstitial Lung Disease |
4.0% |
| Lipase Increased |
4.0% |
| Muscular Weakness |
4.0% |
| Myalgia |
4.0% |
| Porphyria Non-acute |
4.0% |
| Pseudo Lymphoma |
4.0% |
| Rectal Haemorrhage |
4.0% |
| Subdural Haematoma |
4.0% |
| Tonic Clonic Movements |
4.0% |
| Urticaria |
4.0% |
| Vomiting |
4.0% |
| Weight Decreased |
4.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
40.8% |
| Product Used For Unknown Indication |
9.2% |
| Hypertension |
8.8% |
| Hypercholesterolaemia |
5.0% |
| Prophylaxis |
4.0% |
| Dyslipidaemia |
3.3% |
| Ill-defined Disorder |
2.9% |
| Insomnia |
2.9% |
| Unevaluable Event |
2.9% |
| Depression |
2.7% |
| Lung Infection |
2.5% |
| Type 2 Diabetes Mellitus |
2.5% |
| Arteriosclerosis Obliterans |
1.9% |
| Sinusitis |
1.9% |
| Atrial Fibrillation |
1.7% |
| Angina Pectoris |
1.5% |
| Diarrhoea |
1.5% |
| Hiv Infection |
1.5% |
| Cardiac Failure |
1.3% |
| Epilepsy |
1.3% |
|
| Rectal Haemorrhage |
10.3% |
| Interstitial Lung Disease |
9.0% |
| Colitis Ischaemic |
7.7% |
| Tendonitis |
7.7% |
| Renal Failure Acute |
6.4% |
| Thrombocytopenia |
6.4% |
| Anaemia Haemolytic Autoimmune |
5.1% |
| Diarrhoea |
5.1% |
| Rhabdomyolysis |
5.1% |
| Subdural Haematoma |
5.1% |
| Transaminases Increased |
5.1% |
| Toxic Skin Eruption |
3.8% |
| Tricuspid Valve Disease |
3.8% |
| Weight Decreased |
3.8% |
| Dermatitis Exfoliative |
2.6% |
| Pancreatitis Acute |
2.6% |
| Pruritus |
2.6% |
| Pseudo Lymphoma |
2.6% |
| Shock |
2.6% |
| Sudden Death |
2.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
36.0% |
| Hypertension |
14.2% |
| Product Used For Unknown Indication |
10.7% |
| Bronchitis |
3.9% |
| Hypercholesterolaemia |
3.5% |
| Type 2 Diabetes Mellitus |
3.5% |
| Hiv Infection |
3.3% |
| Pain |
3.0% |
| Atrial Fibrillation |
2.3% |
| Osteoporosis |
2.1% |
| Myocardial Infarction |
2.0% |
| Premedication |
1.9% |
| Renal Transplant |
1.9% |
| Non-hodgkin's Lymphoma |
1.7% |
| Depression |
1.6% |
| Diabetes Mellitus |
1.6% |
| Dyslipidaemia |
1.6% |
| Ill-defined Disorder |
1.6% |
| Pneumonia |
1.6% |
| Rheumatoid Arthritis |
1.6% |
|
| Renal Failure Acute |
12.8% |
| Thrombocytopenia |
9.6% |
| Vomiting |
9.0% |
| Weight Decreased |
7.7% |
| Renal Failure |
5.8% |
| Malaise |
5.1% |
| Pyrexia |
4.5% |
| Somnolence |
4.5% |
| Toxic Skin Eruption |
4.5% |
| Sudden Death |
3.8% |
| Syncope |
3.8% |
| Transplant Rejection |
3.8% |
| Anaemia |
3.2% |
| Drug Interaction |
3.2% |
| Hepatitis |
3.2% |
| International Normalised Ratio Increased |
3.2% |
| Neutropenia |
3.2% |
| Pulmonary Oedema |
3.2% |
| Transaminases Increased |
3.2% |
| Hypertension |
2.6% |
|
| Interacting |
| Osteoporosis |
33.3% |
| Drug Use For Unknown Indication |
16.7% |
| Hypercholesterolaemia |
16.7% |
| Hypothyroidism |
16.7% |
| Smoking Cessation Therapy |
16.7% |
|
| Drug Interaction |
25.0% |
| International Normalised Ratio Increased |
25.0% |
| Pain In Extremity |
25.0% |
| Urticaria |
25.0% |
|
